Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells.
about
Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its DerivativesTargeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer CellsThe Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside IIIcariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signalingPreparation of a nanoscale baohuoside I-phospholipid complex and determination of its absorption: in vivo and in vitro evaluations.Icaritin Inhibits Collagen Degradation-Related Factors and Facilitates Collagen Accumulation in Atherosclerotic Lesions: A Potential Action for Plaque Stabilization.Enzymatic features of the glucose metabolism in tumor cells.Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and Solutol HS 15.Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.Effect of β-cyclodextrin complexation on solubility and enzymatic hydrolysis rate of icariin.Icariside II promotes osteogenic differentiation of bone marrow stromal cells in beagle canine.Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma.Ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry analysis of icariside II metabolites in rats
P2860
Q26738330-3A5D29D3-F55B-4684-BF6B-4BFEAE9DC727Q26798203-3ADB133F-0FAE-4B8E-8D7F-4DADB7EA4D50Q28070895-34629BE0-FFF2-443D-B9B1-B4F47B5522FFQ28482163-17321A54-1D3E-4122-B967-AEDDE6D97187Q36247058-84053E3A-F44E-4F97-AC39-D738479BC454Q36666983-1EB4EADE-1586-4858-BE6D-6CFE4C2EFE94Q37874709-CF3E9B05-77F9-45D7-B146-468B49DADC4AQ38718182-C89DDD3C-3953-42D9-A263-803AA3B926BDQ38813835-3B897DB0-3D73-4671-B3AB-C75E71776CE7Q39201613-44CF49F1-361F-43D5-85FE-24650403F4BFQ40011546-B3DD0BEB-451B-4E7D-A139-D5A8DEA54997Q40012265-2336E5EB-F35F-4D0B-B01E-90B5CB2AC387Q41640132-A80E5055-A077-4DC2-AA48-5FEEA981E409Q47271790-D4AC07DD-5FCF-4976-81AE-8EB8E3F988A0Q57154857-9BA1289A-AF6F-4FD8-BFF9-69A02697C929
P2860
Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Icariside II from Epimedium ko ...... a in human osteosarcoma cells.
@en
type
label
Icariside II from Epimedium ko ...... a in human osteosarcoma cells.
@en
prefLabel
Icariside II from Epimedium ko ...... a in human osteosarcoma cells.
@en
P2093
P1476
Icariside II from Epimedium ko ...... a in human osteosarcoma cells.
@en
P2093
Dae Keun Kim
Hwa Jung Choi
Hyunsung Park
Jae-Soon Eun
Nam-Pyo Cho
Tae-Yong Shin
P356
10.1016/J.EJPHAR.2007.10.010
P407
P577
2007-10-15T00:00:00Z